|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Locally advanced pancreatic cancer 显示文摘 | Willett CG Czito BG Bendell JC | 2005 | J Clin Oncol2005，23，20： | 1 |
| 2 | A drug interaction studyevaluating the pharmacokinetics and toxicity of sorafenib in combina-tion with capecitabine 显示文摘 | Infante JR Jones SF Bendell JC | 2012 | Cancer Chemother Pharmacol2012，69，： | 1 |
| 3 | Phase I,dose-escalation study of BKM120, an oral pan-Class I PI3Kinhibitor, in patients with advanced solid tumors 显示文摘 | Bendell JC Rodon J Burris HA | 2012 | J ClinOncol2012，30，3： | 1 |
| 4 | Axitinib or bevacizumab plus FOLFIRI or modified FOLFOX-6 after failure of first-line therapy for metastatic colorectal cancer: a randomized phase 1 study显示文摘 | Bendell JC Tournigand C Swieboda-Sadlej A | 2013 | Clin Colorectal Cancer2013，12，4： | 1 |
| 5 | CentSral nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast earcinoma显示文摘 | Bendell JC Domchek SM Burstein HJ | 2003 | Caneer2003，97，： | 1 |
| 6 | Treatment patterns and clinical outcomes in patients withmetastatic colorectal cancer initially treated with FOLFOXbevacizumabor FOLFIRI-bevacizumab :results from ARIES,a bevacizumab observational cohort study 显示文摘 | BENDELL JC BEKAI I-SAAB TS COHN AL | 2012 | Oncologist2012，17，12： | 1 |
| 7 | A phase I dose-escalation study of IMGN388 in patients with solid tumors显示文摘 | Thompson DS Patnaik A Bendell JC | 2010 | J Clin Oncol2010，28，： | 1 |
| 8 | Phase Ⅰ,dose-escalation study of BKM 120,an oral pan-Class Ⅰ P13K inhibitor,in patients with advanced solid tumors显示文摘 | Bendell JC Rodon J Burris HA | 2012 | J Clin Oncol2012，30，3： | 1 |
| 9 | Phase II study of bev- acizumab and ehemoradiation in the preoperative or adjuvant treat-merit of patients with stage IL/III rectalcancer显示文摘 | Spigel DR Bendell JC McCleod M | 2012 | Clin Co[orectal Cancer2012，11，： | 1 |
| 10 | Phase I, dose- escalation study of BKM120, an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors显示文摘 | Bendell JC Rodon J Burris H A | 2012 | Journal of Clinical Oncology2012，30，3： | 1 |
| 11 | Updated effica- cy of the MEK inhibitor trametinib(T),BRAF inhibitor dabrafenib (D),and anti-EGFR antibody panitumumab (P)in patients(pts)with BRAF V600E mutated(BRAFm) metastatic colorectal cancer (mCRC) 显示文摘 | Atreya CE Cutsem EV Bendell JC | 2015 | J Clin Oncol2015，33，15： | 1 |
| 12 | A phase II trial of preoperative concurrent chemotherapy/radiation therapy plus bevacizumab/erlotinib in the treatment of localized esophageal Cancer显示文摘 | Bendell JC Meluch A Peyton J | | 0，，07： | 1 |
| 13 | Increased toxicity with gefitinib, capecitabine, and radiation therapy in pancreatic and rectal cancer phase 1 trial results 显示文摘 | Czito BG Willett CG Bendell JC | 2006 | J Clin Oncol2006，24，4： | 1 |
| 14 | Locally advanced pancreatic cancer显示文摘 | Willett CG Czito BG Bendell JC | 2005 | J Clin Oncol2005，23，20： | 1 |
| 15 | Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma显示文摘 | Bendell JC Domchek SM Burstein HJ | 2003 | Cancer2003，97，： | 1 |
| 16 | Centra nervous system metastases in women who receive trastuzumab- based therapy for metastatic breast carcinoma显示文摘 | Bendell JC Domchek SM Burstein HJ | 2003 | Cancer2003，97，： | 1 |
| 17 | Be- vacizumab, oxaliplatin, and eapecitabine with radiation therapy in rectal cancer: Phase I trial resuhs显示文摘 | Czito BG Bendell JC Willett CG | 2007 | Int J Radiat Oncol Biol Phys2007，68，2： | 1 |
| 18 | A phase I dose-escala-tion study of IMGN388 in patients with solid tumors 显示文摘 | Thompson DS Patnaik A Bendell JC | 2010 | J Clin Oncol2010，28，15： | 1 |
| 19 | A phaseⅡtrial of preoperative concurrent chemotherapy/radiation therapy plus bevacizumab/erlotinib in the treatment of localized esophageal cancer显示文摘 | Bendell JC Meluch A Peyton J | 2012 | Clin Adv Hematol Oncol2012，10，7： | 1 |
| 20 | Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma 显示文摘 | Bendell JC Domchek SM Burstein HJ | 2003 | Cancer2003，97，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员